{"public_id":"cl_a1bdc319081d680de44b0b3ae160e9c1","status":"active","superseded_by_public_id":null,"corpus_id":27608012,"text":"The clinical significance of mildly antagonistic dihydroartemisinin combinations is uncertain and may become important if parasite drug sensitivity declines.","confidence":0.84,"paper":{"corpus_id":27608012,"title":"In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs","url":"https://sah.borca.ai/papers/27608012"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.84,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2a97c86e28059ca1a86f132a5aecdb68","name":"dihydroartemisinin","description":"An artemisinin-derived antimalarial drug evaluated in combination with other agents.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_2a97c86e28059ca1a86f132a5aecdb68"},{"public_id":"co_3b1a781d519592011745023e9646e499","name":"mildly antagonistic","description":"A weak interaction in which the combined effect is less favorable than expected.","types":["interaction property"],"url":"https://sah.borca.ai/concepts/co_3b1a781d519592011745023e9646e499"},{"public_id":"co_7db19b32a862ed93880f13172f8d9f10","name":"parasite drug sensitivity","description":"The susceptibility of malaria parasites to antimalarial drugs.","types":["biological property"],"url":"https://sah.borca.ai/concepts/co_7db19b32a862ed93880f13172f8d9f10"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_a1bdc319081d680de44b0b3ae160e9c1"}